| ²é¿´: 568 | »Ø¸´: 3 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
[ÇóÖú]
ÇóÖúÒ»¶Î»°·Ò룬ллÁËŶ£¬ÒªÊÖ¹¤»î£¬Ð»¾øÍêÈ«»úÆ÷·Òë
|
||
| Afterwards, the same research also investigated the inhibitory potency of the equivalent trimeric form of C34 as an antigen peptide producing structure-specific antibodies. The antiserum produced by immunization of the C34 trimeric form antigen demonstracted 23-fold higher binding affinity for the C34 trimer than for the C34 monomer and showed significant neutralizing activity [22]. |
» ²ÂÄãϲ»¶
081700£¬311£¬Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ18È˻ظ´
085600²ÄÁÏÓ뻯¹¤301·ÖÇóµ÷¼ÁԺУ
ÒѾÓÐ4È˻ظ´
²ÄÁÏÓ뻯¹¤371Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
336²ÄÁÏÓ뻯¹¤085600Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
²ÄÁÏ334Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
331Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
332Çóµ÷¼Á
ÒѾÓÐ17È˻ظ´
Ò»Ö¾Ô¸ÄϾ©º½¿Õº½Ìì´óѧ ²ÄÁÏÓ뻯¹¤329·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏר˶322
ÒѾÓÐ7È˻ظ´

Ƶ»Øíííù
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 110
- Ó¦Öú: 13 (СѧÉú)
- ¹ó±ö: 0.566
- ½ð±Ò: 17171.4
- É¢½ð: 1586
- ºì»¨: 30
- ɳ·¢: 3
- Ìû×Ó: 3338
- ÔÚÏß: 545.1Сʱ
- ³æºÅ: 1238300
- ×¢²á: 2011-03-19
- ÐÔ±ð: GG
- רҵ: ½ðÊôÓлú»¯Ñ§
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
°®ÓëÓêÏÂ: ½ð±Ò+1 2012-05-17 21:35:53
sltmac: ½ð±Ò+4 2012-05-28 08:21:45
°®ÓëÓêÏÂ: ½ð±Ò+1 2012-05-17 21:35:53
sltmac: ½ð±Ò+4 2012-05-28 08:21:45
| ºóÀ´£¬ÎÒÃÇ×öÁËÏàͬµÄÑо¿£¬µ÷²éÁË C34 µÄµÈЧÈýÁªÐÎʽ×÷ΪÉú²ú½á¹¹ÌØÒìÐÔ¿¹ÌåµÄ¿¹ÔëÄÒÖÖÆÐ§Á¦¡£ÃâÒß½ÓÖÖ C34 ÈýÁªÌ忹ԲúÉúµÄ¿¹ÑªÇåÏÔʾ¾¹ý23´ÎÕÛµþµÄC34 Èý¾ÛÌå±ÈC34 µ¥Ìå¼üºÏÐÔ¸üÇ¿¶øÇÒÖкͻîÐÔ¸üÍ»³ö [22]¡£ |

2Â¥2012-05-11 12:05:26

3Â¥2012-05-14 23:39:02
8814402
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 509
- Ó¦Öú: 18 (СѧÉú)
- ¹ó±ö: 0.381
- ½ð±Ò: 12916.1
- É¢½ð: 47
- ºì»¨: 16
- Ìû×Ó: 4183
- ÔÚÏß: 357.8Сʱ
- ³æºÅ: 1184404
- ×¢²á: 2011-01-06
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
°®ÓëÓêÏÂ: ½ð±Ò+1 2012-05-17 21:36:00
sltmac: ½ð±Ò+6, ·ÒëEPI+1 2012-05-28 08:21:51
°®ÓëÓêÏÂ: ½ð±Ò+1 2012-05-17 21:36:00
sltmac: ½ð±Ò+6, ·ÒëEPI+1 2012-05-28 08:21:51
| Afterwards, the same research also investigated the inhibitory potency of the equivalent trimeric form of C34 as an antigen peptide producing structure-specific antibodies. È»ºó£¬Í¬Ò»¿ÎÌ⻹Ñо¿ÁËC34µÄµÈÁ¿Èý¾ÛÌå×÷ΪÓÕ·¢½á¹¹ÌØÒìÐÔ¿¹ÌåµÄ¿¹ÔëĵÄÒÖÖÆ¼ÁЧÄÜ¡£The antiserum produced by immunization of the C34 trimeric form antigen demonstracted 23-fold higher binding affinity for the C34 trimer than for the C34 monomer and showed significant neutralizing activity [22].Ñо¿±íÃ÷£¬ÓÉC34Èý¾ÛÌ忹ÔÃâÒßÉú³ÉµÄ¿¹ÑªÇ壨ÃâÒßµ°°×£©µÄ½áºÏÁ¦ÎªC34µ¥ÌåËùÃâÒßÉú³ÉÕßµÄ23±¶£¬¶øÇÒÏÔʾÁËÖµµÃ×¢ÒâµÄÖкͻîÐÔ¡£ |
4Â¥2012-05-15 08:18:17














»Ø¸´´ËÂ¥